BRIEF-Com Hem Q1 operating profit increases
* Q1 revenue saw a increase of 37.7% to SEK 1,757m while organic revenue rose by 3.5% to SEK 1,321m.
Dec 22 Biocartis Group NV :
* Biocartis and Amgen sign a RAS Biomarker testing collaboration in Europe
* This new agreement, which builds on existing collaboration between companies announced on February, aims at accelerating access to RAS Biomarker information in up to 10 European countries Source text for Eikon: Further company coverage: (Gdynia Newsroom)